Literature DB >> 34898644

Correction: Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0253216.].

Entities:  

Year:  2021        PMID: 34898644      PMCID: PMC8668109          DOI: 10.1371/journal.pone.0261515

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There are errors in Fig 1. Several of the labels are incorrect. The authors have provided a corrected version here. The publisher apologizes for the errors.
Fig 1

Queuine integration into tRNAs.

In eukaryotic cells, the tRNA guanine transglycosylase (TGT) enzyme exchanges guanine (G) with the nucleobase queuine (q) at the wobble position (position 34, first base of the anticodon) of tRNAs that contain a GUN anticodon sequence (N = any base) and are specific to tRNA isoacceptors for tyrosine (tRNATyr), asparagine (tRNAAsn), aspartic acid (tRNAAsp) and histidine (tRNAHis). Queuosine (Q) is the corresponding nucleoside of q and Q-tRNA base-pairing with NAY codons (Y = C or U) impacts speed and fidelity of mRNA translation [14, 20–22].

Queuine integration into tRNAs.

In eukaryotic cells, the tRNA guanine transglycosylase (TGT) enzyme exchanges guanine (G) with the nucleobase queuine (q) at the wobble position (position 34, first base of the anticodon) of tRNAs that contain a GUN anticodon sequence (N = any base) and are specific to tRNA isoacceptors for tyrosine (tRNATyr), asparagine (tRNAAsn), aspartic acid (tRNAAsp) and histidine (tRNAHis). Queuosine (Q) is the corresponding nucleoside of q and Q-tRNA base-pairing with NAY codons (Y = C or U) impacts speed and fidelity of mRNA translation [14, 20–22].
  1 in total

1.  Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.

Authors:  Patricia Richard; Lucie Kozlowski; Hélène Guillorit; Patrice Garnier; Nicole C McKnight; Antoine Danchin; Xavier Manière
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.